Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ruohong Shui

Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers Treated With Neoadjuvant Chemotherapy

Targeted Oncology

English

Related publications

PB.40. What Happens to the Ductal Carcinoma in Situ in HER2-positive Cancers Treated With Neoadjuvant Chemotherapy and Trastuzumab?

Breast Cancer Research

Cancer Research

Oncology

2014

English

Prognostic and Predictive Values of EGFR Overexpression and EGFR Copy Number Alteration in HER2-positive Breast Cancer

British Journal of Cancer

Cancer Research

Oncology

2014

English

Clinical Significance and Prognostic Value of Receptor Conversion in Hormone Receptor Positive Breast Cancers After Neoadjuvant Chemotherapy

World Journal of Surgical Oncology

Surgery

Oncology

2018

English

Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting

English

Prognostic Value of HER2 to CEP17 Ratio on Fluorescence in Situ Hybridization Ratio in Patients With Nonmetastatic HER2‐Positive Inflammatory and Noninflammatory Breast Cancer Treated With Neoadjuvant Chemotherapy With or Without Trastuzumab

English

Evaluation of Prognostic Factors and Validation of Tumor Response Ratios After Neoadjuvant Chemotherapy in Patients With Breast Cancer

Journal of Breast Disease

2016

English

Erratum To: Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Breast Cancer and Its Clinical Significance

Breast Cancer Research

Cancer Research

Oncology

2017

English

Prognostic and Predictive Role of Tumour-Associated Macrophages in HER2 Positive Breast Cancer

Scientific Reports

Multidisciplinary

2019

English

Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ruohong Shui

Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers Treated With Neoadjuvant Chemotherapy

Related publications

PB.40. What Happens to the Ductal Carcinoma in Situ in HER2-positive Cancers Treated With Neoadjuvant Chemotherapy and Trastuzumab?

Prognostic and Predictive Values of EGFR Overexpression and EGFR Copy Number Alteration in HER2-positive Breast Cancer

Clinical Significance and Prognostic Value of Receptor Conversion in Hormone Receptor Positive Breast Cancers After Neoadjuvant Chemotherapy

Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting

Prognostic Value of HER2 to CEP17 Ratio on Fluorescence in Situ Hybridization Ratio in Patients With Nonmetastatic HER2‐Positive Inflammatory and Noninflammatory Breast Cancer Treated With Neoadjuvant Chemotherapy With or Without Trastuzumab

Evaluation of Prognostic Factors and Validation of Tumor Response Ratios After Neoadjuvant Chemotherapy in Patients With Breast Cancer

Erratum To: Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Breast Cancer and Its Clinical Significance

Prognostic and Predictive Role of Tumour-Associated Macrophages in HER2 Positive Breast Cancer

Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy